Vaccination of mice with DNA encoding a large fragment of botulinum neurotoxin serotype A

By Clayton J.   Middlebrook J.L.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1855-1862

Elsevier

Access to resources Recommend Favorite

Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT/F H C fragment

By Foynes S.   Holley J.L.   Garmory H.S.   Titball R.W.   Fairweather N.F.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1052-1059

Elsevier

Access to resources Recommend Favorite

Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum

By Dertzbaugh M.T.   West M.W.  

Vaccine, Vol. 14, Iss. 16, 1996-11 ,pp. : 1538-1544

Elsevier

Access to resources Recommend Favorite

Identifying the principal protective antigenic determinants of type A botulinum neurotoxin

By Bavari S.   Pless D.D.   Torres E.R.   Lebeda F.J.   Olson M.A.  

Vaccine, Vol. 16, Iss. 19, 1998-11 ,pp. : 1850-1856

Elsevier

Access to resources Recommend Favorite

DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission

By Couper K.N.   Nielsen H.V.   Petersen E.   Roberts F.   Roberts C.W.   Alexander J.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2813-2820

Elsevier

Access to resources Recommend Favorite